Related Experiment Video
Updated: Aug 5, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Distribution-based covariate assessment using wasserstein distance in population pharmacokinetic models
Nicolas Simon1, Jean-Sebastien Hulot2,3, Katharina von Fabeck1
1Department of Clinical Pharmacology, APHM, Institut de Neurosciences de la Timone, UMR7289, CNRS, Hôpital Sainte Marguerite, CAP-TV, Aix Marseille University, Marseille, France.
Wasserstein distance offers a new way to check covariate relationships in pharmacokinetic models, improving precision dosing. This distribution-based method complements existing techniques, especially for complex non-linear patterns.
Area of Science:
- Pharmacometrics
- Pharmacokinetics
- Systems Biology
Background:
- Population pharmacokinetic (PopPK) modeling is crucial for explaining interindividual variability and enabling model-informed precision dosing.
- Existing validation methods using likelihood-based criteria and correlation analyses may miss complex non-linear covariate relationships.
- There is a need for complementary methods to assess covariate specification in PopPK models.
Purpose of the Study:
- To introduce and validate the Wasserstein distance as a complementary metric for assessing covariate specification in PopPK models.
- To evaluate the Wasserstein distance's ability to detect complex non-linear and non-monotonic covariate relationships.
- To quantify variance reduction using a Wasserstein-based R² metric.
Main Methods:
- Developed three nested PopPK models for high-dose methotrexate in 50 patients with lymphoid malignancies.
- Calculated Wasserstein distances between empirical parameter deviation distributions stratified by covariate groups (e.g., ABCC2 polymorphism, creatinine clearance).
- Assessed statistical significance using permutation testing and defined a Wasserstein-based R² for variance reduction. Simulation studies were used to illustrate detection of various covariate effects.
Main Results:
- The FINAL model, incorporating genetic and creatinine clearance covariates, showed no residual distributional differences (CT01: W = 0.071, p = 0.741), indicating adequate specification.
- The Wasserstein-based R² demonstrated progressive variance reduction: 21.5% for the GENET_ALL model and 31.7% for the FINAL model.
- Simulation studies confirmed the utility of the Wasserstein-based approach in identifying complex non-linear covariate relationships, complementing traditional methods.
Conclusions:
- Wasserstein distance provides a robust, distribution-based framework for validating covariate specification in PopPK models with minimal parametric assumptions.
- This method is particularly valuable for detecting complex non-linear covariate relationships that might be missed by conventional techniques.
- The approach is reliable when eta-shrinkage is sufficiently low with empirical Bayes estimates.
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Dosage Regimens: Partial Pharmacokinetic Parameters
